Japan· JP-2119404G4052
ドブタミン塩酸塩
A dobutamine product containing ドブタミン塩酸塩, registered in Japan by 共和薬品工業, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Dobutamine is registered in 18 of 19 countries.
Countries holding a registration under ATC C01CA07 (dobutamine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Dobutamine · ATC C01CA07
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ドブタミン塩酸塩
- Manufacturer
- 共和薬品工業
- Country
- Japan (JP)
- ATC code
- C01CA07
- ATC class
- Dobutamine
- Defined daily dose
- 0.5 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
131 interactions on record for dobutamine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dobutamine · interactions on record
131 records
- 3 severe
- 89 moderate
- 39 info
Most severe, free to view
- CocaineN01BC01severe
- DoxepinN06AA12severe
- CocaineR02AD03severe
- CimetidineA02BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01CA07
Dobutamine, as other registers publish it.
- FinlandDobujectSchering Oy
- FinlandDobujectSchering Oy
- FinlandDobujectPrimex Pharmaceuticals Oy
- GermanyDobutaminCarinopharm Gmbh
- FinlandDobutamin AbbottAbbott Scandinavia AB
- FinlandDobutamin AbbottAbbott Scandinavia AB
- CzechiaDOBUTAMIN ADMEDAAdmeda Arzneimittel GmbH, Hamburg
- GermanyDobutamin CarinopharmCarinopharm Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa599e02-62c0-484e-a4f3-6280e642eeee GET /v1/drugs/aa599e02-62c0-484e-a4f3-6280e642eeee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．３％２００ｍＬ１袋",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2119404G4052",
"category": "注射薬",
"price_yen": 1575,
"generic_name": "ドブタミン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2119",
"transitional_expiry": null
}See everything about dobutamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.